Image Credit: STAT News

STAT+: Kura licenses leukemia drug to Japanese drugmaker

Watchdoq November 20, 2024

Kura Oncology has signed a global partnership with Japanese drugmaker Kyowa Kirin to develop and sell an experimental leukemia treatment